Sonoma Pharmaceuticals
SNOA
SNOA
22 hedge funds and large institutions have $870K invested in Sonoma Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.05% less ownership
Funds ownership: 0.1% → 0.04% (-0.05%)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$77K | |
| 2 | +$67K | |
| 3 | +$42K | |
| 4 |
Goldman Sachs
New York
|
+$22K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.5K |
Top Sellers
| 1 | -$331K | |
| 2 | -$58K | |
| 3 | -$3.42K | |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$3.05K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$3K |